These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7875230)

  • 1. Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies.
    Wanibuchi F; Nishida T; Yamashita H; Hidaka K; Koshiya K; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1994 Nov; 265(3):151-8. PubMed ID: 7875230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.
    Suzuki M; Yamaguchi T; Ozawa Y; Ohyama M; Yamamoto M
    J Pharmacol Exp Ther; 1995 Nov; 275(2):728-36. PubMed ID: 7473160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
    Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice.
    Suzuki M; Yamaguchi T; Ozawa Y; Iwai A; Yamamoto M
    Pharmacol Biochem Behav; 1995 Aug; 51(4):623-6. PubMed ID: 7675834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
    Tsukamoto S; Nagaoka H; Igarashi S; Wanibuchi F; Hidaka K; Tamura T
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists.
    Tsukamoto S; Fujii M; Yasunaga T; Matsuda K; Wanibuchi F; Hidaka K; Furuya T; Tamura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):842-52. PubMed ID: 7553970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new muscarinic M1-receptor agonist YM796 evokes yawning and increases oxytocin secretion from the posterior pituitary gland in rats.
    Fujikawa M; Yamada K; Nagashima M; Domae M; Furukawa T
    Pharmacol Biochem Behav; 1996 Sep; 55(1):55-60. PubMed ID: 8870038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YM796, a novel muscarinic agonist, improves the impairment of learning behavior in a rat model of chronic focal cerebral ischemia.
    Yamaguchi T; Suzuki M; Yamamoto M
    Brain Res; 1995 Jan; 669(1):107-14. PubMed ID: 7712153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor gene.
    Wei HB; Roeske WR; Lai J; Wanibuchi F; Hidaka K; Usuda S; Yamamura HI
    Life Sci; 1992; 50(5):355-63. PubMed ID: 1310135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats.
    Yoshida S; Suzuki N
    Eur J Pharmacol; 1993 Nov; 250(1):117-24. PubMed ID: 8119309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
    Bymaster FP; Carter PA; Peters SC; Zhang W; Ward JS; Mitch CH; Calligaro DO; Whitesitt CA; DeLapp N; Shannon HE; Rimvall K; Jeppesen L; Sheardown MJ; Fink-Jensen A; Sauerberg P
    Brain Res; 1998 Jun; 795(1-2):179-90. PubMed ID: 9622623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the rate-limiting step in the hepatic elimination of YM796 by isolated rat hepatocytes.
    Iwatsubo T; Suzuki H; Sugiyama Y
    Pharm Res; 1999 Jan; 16(1):110-6. PubMed ID: 9950288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
    Dronfield S; Egan K; Marsden CA; Green AR
    J Psychopharmacol; 2000; 14(3):275-9. PubMed ID: 11106308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa analogues of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione.
    Tsukamoto S; Ichihara M; Wanibuchi F; Usuda S; Hidaka K; Harada M; Tamura T
    J Med Chem; 1993 Aug; 36(16):2292-9. PubMed ID: 8360873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.
    Iwatsubo T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.
    Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ(1-42)-induced cognitive dysfunction in mice.
    Park SJ; Jung JM; Lee HE; Lee YW; Kim DH; Kim JM; Hong JG; Lee CH; Jung IH; Cho YB; Jang DS; Ryu JH
    J Ethnopharmacol; 2012 Sep; 143(2):611-20. PubMed ID: 22846435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 2002 Apr; 301(1):187-96. PubMed ID: 11907173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats.
    Sadek B; Khan N; Darras FH; Pockes S; Decker M
    Physiol Behav; 2016 Oct; 165():383-91. PubMed ID: 27568232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.